Liver precancerous lesions and hepatocellular carcinoma: The histology report

Digestive and Liver Disease

Volumn 43, Issue SUPPL. 4, 2011, Pages

  Roncalli, Massimo ^a   Terracciano, Luigi ^b   Di Tommaso, Luca ^a   David, Ezio ^c   Colombo, Massimo ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c MOLINETTE HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Dysplastic nodules; GIPAD report; Hepatocellular carcinoma; Liver metastases

Indexed keywords

ALPHA FETOPROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; EXPLANT; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER NODULE; PRECANCER; PRIORITY JOURNAL; SAMPLING;

BIOPSY; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; HUMANS; LIVER; LIVER NEOPLASMS; PATHOLOGY; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953210046     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(11)60592-6     Document Type: Article

References (21)

1. Sherman M Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis. Semin Liv Dis 2010, 30:3-16.
2. Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005, 42:27-34.
3. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the non-invasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008, 47:97-104.
4. Sangiovanni A, Manini MA, Iavarone M, et al. The diagnostic and economic impact of contrast imaging technique in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010, 59:638-644.
5. Leoni S, Piscaglia F, Golfieri R, et al. The impact of vascular and non vascular findings on the non invasive diagnosis of small hepatocellular carcinoma based on EASL and AASLD criteria. Am J Gastroenterol 2010, 105:599-609.
6. Borzio M, Fargion S, Borzio F, et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 2003, 39:208-214.
7. Kobayashi M, Ikeda K, Hosaka T, et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer 2006, 106:636-647.
8. International Consensus Group for Hepatocellular Neoplasia Pathologic diagnosis of early hepatocellular carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 2009, 49:658-664.
9. Park YN, Kojiro M, Di Tommaso L, et al. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 2007, 109(5):915-923.
10. Llovet JM, Chen Y, Wurmbach E, et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006, 131:1758-1767.
11. Di Tommaso L, Destro A, Seok JY, et al. The application of a panel of markers (HSP 70, GPC3, GS) in liver biopsies is useful for HCC detection. J Hepatol 2009, 50:746-754.
12. Lennerz JKM, Crippin JS, Brunt ME Diagnostic considerations of nodules in the cirrhotic liver. A case-based Perspective. Pathology Case Reviews 2009, 14:3-12.
13. Burt AD, Portmann BC, Ferrell LD MacSween's Pathology of the Liver 2007, 783-784. Churchill Livingstone Elsevier. 5th edition.
14. Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 2009, 137:850-855.
15. Ng IO, Guan XY, Poon RT Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J Pathol 2003, 199:345-353.
16. Melato M, Laurino L, Mucli E, et al. Relationship between cirrhosis, liver cancer, and hepatic metastases. Cancer 1989, 64:455-459.
17. Bralet MP, Régimbeau JM, Pineau P, et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000, 32:200-204.
18. Ishak KG, Goodman ZD, Stocker JT. Tumors of the liver and intrahepatic bile ducts. Atlas of Tumor Pathology, AFIP, Fascicle 31, Third series, Washington D.C., 2001.
19. Lugli A, Tornillo L, Mirlacher M, et al. Hepatocyte paraffin-1 (Hep Par-1) expression in human normal and neoplastic tissues: A tissue microarray (TMA) analysis on 3940 tissue samples. Am J Clin Pathol 2004, 122:721-727.
20. Rullier A, Le Bail B, Fawaz R, et al. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 2000, 24:870-876.
21. Kakar S, Gown AM, Goodman ZD, et al. Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med 2007, 131:1648-1654.